Is DFTX or LIVN more profitable?

LIVN runs the higher net margin — DFTX at 0.00% versus LIVN at 12.82%.

How have DFTX and LIVN total returns compared?

Over the past 5 years, DFTX delivered 1.43% and LIVN delivered -1.66% annualized total return. Past performance doesn't predict future results.

Definium Therapeutics, Inc. (DFTX) vs LivaNova PLC (LIVN)

A side-by-side comparison of Definium Therapeutics, Inc. and LivaNova PLC across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

DFTX

Definium Therapeutics, Inc.

$4.68B

$35.23HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT

LIVN

LivaNova PLC

$4.15B

$75.47HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT

Total return — DFTX vs LIVN

growth of $100 · dividends reinvested · last 10y

DFTX +971.9% (+26.8%/yr)LIVN +83.3% (+6.2%/yr)DFTX compounded faster over this window

Log scale — wide-divergence pair

DFTX LIVN

DFTX vs LIVN: by the numbers

•DFTX is the larger company ($4.68B vs $4.15B market cap).
•LIVN is profitable (12.82% net margin) while DFTX runs a net loss (0.00%).

Metrics side by side

Valuation

Metric	DFTX	LIVN
P/E ratio	N/A	22.26
Forward P/E	N/A	17.33
P/S ratio	N/A	2.82
P/B ratio	5.09	3.13
EV / EBITDA	N/A	16.29
FCF yield	N/A	3.58%

Profitability

Metric	DFTX	LIVN
Gross margin	0.00%	68.18%
Operating margin	0.00%	13.48%
Net margin	0.00%	12.82%
ROE	-38.51%	14.23%
ROIC	-23.81%	10.24%

Growth (annualized)

Metric	DFTX	LIVN
Revenue CAGR (5Y)	N/A	7.57%
FCF CAGR (5Y)	N/A	20.23%
Total return CAGR (5Y)	1.43%	-1.66%

Frequently asked

Is DFTX or LIVN more profitable?: LIVN runs the higher net margin — DFTX at 0.00% versus LIVN at 12.82%.
How have DFTX and LIVN total returns compared?: Over the past 5 years, DFTX delivered 1.43% and LIVN delivered -1.66% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DFTX analysis Full LIVN analysis Interactive comparison tool

Dig into the metrics

LivaNova P/E ratio Definium Therapeutics ROE LivaNova ROE Definium Therapeutics operating margin LivaNova operating margin Definium Therapeutics revenue growth LivaNova revenue growth Definium Therapeutics free cash flow LivaNova free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.